EquityIndex FundsVery High Risk
Regular
NAV (12-Sep-25)
Returns (Since Inception)
Fund Size
₹18 Cr
Expense Ratio
1.01%
ISIN
INF194KB1IR4
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
22 Oct 2024
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
Since Inception
+3.89%
— (Cat Avg.)
Equity | ₹18.31 Cr | 100.09% |
Others | ₹-0.02 Cr | -0.09% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | ₹2.34 Cr | 12.79% |
Cipla Ltd | Equity | ₹1.25 Cr | 6.83% |
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹1.19 Cr | 6.48% |
Divi's Laboratories Ltd | Equity | ₹1.08 Cr | 5.92% |
Dr Reddy's Laboratories Ltd | Equity | ₹1.07 Cr | 5.85% |
Apollo Hospitals Enterprise Ltd | Equity | ₹1.06 Cr | 5.82% |
Fortis Healthcare Ltd | Equity | ₹0.66 Cr | 3.61% |
Lupin Ltd | Equity | ₹0.64 Cr | 3.48% |
Torrent Pharmaceuticals Ltd | Equity | ₹0.52 Cr | 2.84% |
Laurus Labs Ltd | Equity | ₹0.46 Cr | 2.53% |
Glenmark Pharmaceuticals Ltd | Equity | ₹0.4 Cr | 2.19% |
Aurobindo Pharma Ltd | Equity | ₹0.4 Cr | 2.18% |
Alkem Laboratories Ltd | Equity | ₹0.4 Cr | 2.17% |
Mankind Pharma Ltd | Equity | ₹0.38 Cr | 2.09% |
Zydus Lifesciences Ltd | Equity | ₹0.34 Cr | 1.88% |
Biocon Ltd | Equity | ₹0.28 Cr | 1.52% |
Ipca Laboratories Ltd | Equity | ₹0.27 Cr | 1.46% |
Krishna Institute of Medical Sciences Ltd | Equity | ₹0.25 Cr | 1.35% |
Cohance Lifesciences Ltd | Equity | ₹0.23 Cr | 1.28% |
Abbott India Ltd | Equity | ₹0.22 Cr | 1.22% |
Gland Pharma Ltd | Equity | ₹0.21 Cr | 1.12% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹0.19 Cr | 1.06% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹0.19 Cr | 1.03% |
Dr. Lal PathLabs Ltd | Equity | ₹0.17 Cr | 0.95% |
Syngene International Ltd | Equity | ₹0.16 Cr | 0.90% |
Wockhardt Ltd | Equity | ₹0.16 Cr | 0.90% |
Narayana Hrudayalaya Ltd | Equity | ₹0.16 Cr | 0.90% |
Neuland Laboratories Ltd | Equity | ₹0.16 Cr | 0.88% |
Global Health Ltd | Equity | ₹0.16 Cr | 0.87% |
GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹0.16 Cr | 0.86% |
Piramal Pharma Ltd | Equity | ₹0.16 Cr | 0.85% |
Ajanta Pharma Ltd | Equity | ₹0.15 Cr | 0.80% |
Concord Biotech Ltd | Equity | ₹0.14 Cr | 0.75% |
Poly Medicure Ltd | Equity | ₹0.11 Cr | 0.61% |
Jubilant Pharmova Ltd | Equity | ₹0.11 Cr | 0.59% |
Pfizer Ltd | Equity | ₹0.11 Cr | 0.59% |
Natco Pharma Ltd | Equity | ₹0.11 Cr | 0.59% |
Rainbow Childrens Medicare Ltd | Equity | ₹0.11 Cr | 0.58% |
Eris Lifesciences Ltd Registered Shs | Equity | ₹0.11 Cr | 0.58% |
Granules India Ltd | Equity | ₹0.1 Cr | 0.54% |
Acutaas Chemicals Ltd | Equity | ₹0.1 Cr | 0.52% |
Metropolis Healthcare Ltd | Equity | ₹0.08 Cr | 0.43% |
Strides Pharma Science Ltd | Equity | ₹0.08 Cr | 0.43% |
Sai Life Sciences Ltd | Equity | ₹0.07 Cr | 0.41% |
AstraZeneca Pharma India Ltd | Equity | ₹0.07 Cr | 0.40% |
Jupiter Life Line Hospitals Ltd | Equity | ₹0.07 Cr | 0.40% |
Alembic Pharmaceuticals Ltd | Equity | ₹0.07 Cr | 0.39% |
Procter & Gamble Health Ltd | Equity | ₹0.07 Cr | 0.39% |
Vijaya Diagnostic Centre Ltd | Equity | ₹0.07 Cr | 0.37% |
Sanofi Consumer Healthcare India Ltd | Equity | ₹0.06 Cr | 0.35% |
Sanofi India Ltd | Equity | ₹0.06 Cr | 0.35% |
Shilpa Medicare Ltd | Equity | ₹0.06 Cr | 0.35% |
Aarti Pharmalabs Ltd | Equity | ₹0.06 Cr | 0.32% |
Indegene Ltd | Equity | ₹0.06 Cr | 0.32% |
Caplin Point Laboratories Ltd | Equity | ₹0.06 Cr | 0.32% |
Marksans Pharma Ltd | Equity | ₹0.05 Cr | 0.26% |
Emcure Pharmaceuticals Ltd | Equity | ₹0.05 Cr | 0.26% |
Net Current Assets | Cash | ₹-0.05 Cr | 0.26% |
Kovai Medical Center & Hospital Ltd | Equity | ₹0.04 Cr | 0.22% |
Alivus Life Sciences Ltd | Equity | ₹0.04 Cr | 0.22% |
HealthCare Global Enterprises Ltd | Equity | ₹0.04 Cr | 0.21% |
Yatharth Hospital and Trauma Care Services Ltd | Equity | ₹0.04 Cr | 0.19% |
FDC Ltd | Equity | ₹0.03 Cr | 0.17% |
Triparty Repo Trp_010925 | Cash - Repurchase Agreement | ₹0.03 Cr | 0.16% |
Sequent Scientific Ltd | Equity | ₹0.03 Cr | 0.15% |
Thyrocare Technologies Ltd | Equity | ₹0.03 Cr | 0.15% |
Indraprastha Medical Corp Ltd | Equity | ₹0.03 Cr | 0.15% |
Solara Active Pharma Sciences Ltd Ordinary Shares | Equity | ₹0.03 Cr | 0.15% |
Dishman Carbogen Amics Ltd | Equity | ₹0.02 Cr | 0.13% |
Supriya Lifescience Ltd | Equity | ₹0.02 Cr | 0.13% |
Morepen Laboratories Ltd | Equity | ₹0.02 Cr | 0.12% |
Aarti Drugs Ltd | Equity | ₹0.02 Cr | 0.12% |
Advanced Enzyme Technologies Ltd | Equity | ₹0.02 Cr | 0.12% |
Blue Jet Healthcare Ltd | Equity | ₹0.02 Cr | 0.12% |
Krsnaa Diagnostics Ltd | Equity | ₹0.02 Cr | 0.11% |
Innova Captab Ltd | Equity | ₹0.02 Cr | 0.11% |
Suven Life Sciences Ltd | Equity | ₹0.02 Cr | 0.10% |
Sun Pharma Advanced Research Co Ltd | Equity | ₹0.02 Cr | 0.10% |
Akums Drugs and Pharmaceuticals Ltd | Equity | ₹0.02 Cr | 0.09% |
Gujarat Themis Biosyn Ltd | Equity | ₹0.02 Cr | 0.09% |
Orchid Pharma Ltd | Equity | ₹0.02 Cr | 0.09% |
IOL Chemicals And Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.08% |
Unichem Laboratories Ltd | Equity | ₹0.01 Cr | 0.08% |
Bliss GVS Pharma Ltd | Equity | ₹0.01 Cr | 0.08% |
Senores Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.08% |
RPG Life Sciences Ltd | Equity | ₹0.01 Cr | 0.08% |
Gufic Biosciences Ltd | Equity | ₹0.01 Cr | 0.08% |
Indoco Remedies Ltd | Equity | ₹0.01 Cr | 0.07% |
Vimta Labs Ltd | Equity | ₹0.01 Cr | 0.07% |
Hikal Ltd | Equity | ₹0.01 Cr | 0.07% |
Windlas Biotech Ltd | Equity | ₹0.01 Cr | 0.06% |
Hester Biosciences Ltd | Equity | ₹0.01 Cr | 0.06% |
Syncom Formulation (India) Ltd | Equity | ₹0.01 Cr | 0.06% |
Artemis Medicare Services Ltd Ordinary Shares | Equity | ₹0.01 Cr | 0.05% |
SMS Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.05% |
Novartis India Ltd | Equity | ₹0.01 Cr | 0.05% |
Suraksha Diagnostic Ltd | Equity | ₹0.01 Cr | 0.04% |
Sigachi Industries Ltd | Equity | ₹0.01 Cr | 0.04% |
Shalby Ltd | Equity | ₹0.01 Cr | 0.04% |
Lincoln Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.04% |
Tarsons Products Ltd | Equity | ₹0.01 Cr | 0.04% |
GPT Healthcare Ltd | Equity | ₹0.01 Cr | 0.03% |
Kopran Ltd | Equity | ₹0.01 Cr | 0.03% |
Themis Medicare Ltd | Equity | ₹0 Cr | 0.02% |
KMC Speciality Hospitals (India) Ltd | Equity | ₹0 Cr | 0.02% |
NGL Fine-Chem Ltd | Equity | ₹0 Cr | 0.02% |
Sastasundar Ventures Ltd | Equity | ₹0 Cr | 0.02% |
Cash Margin - Ccil | Cash - Repurchase Agreement | ₹0 Cr | 0.00% |
Large Cap Stocks
53.98%
Mid Cap Stocks
20.31%
Small Cap Stocks
25.80%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹18.19 Cr | 99.44% |
Basic Materials | ₹0.12 Cr | 0.65% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since March 2025
ISIN INF194KB1IR4 | Expense Ratio 1.01% | Exit Load No Charges | Fund Size ₹18 Cr | Age 10 months | Lumpsum Minimum ₹1,000 | Fund Status Open Ended Investment Company | Benchmark BSE Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹1,83,484 Cr
Address
6th Floor, 841, One World Center, Mumbai, 400013
Your principal amount will be at Very High Risk
EquityIndex FundsVery High Risk
Regular
NAV (12-Sep-25)
Returns (Since Inception)
Fund Size
₹18 Cr
Expense Ratio
1.01%
ISIN
INF194KB1IR4
Minimum SIP
₹1,000
Exit Load
No Charges
Inception Date
22 Oct 2024
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
Since Inception
+3.89%
— (Cat Avg.)
Equity | ₹18.31 Cr | 100.09% |
Others | ₹-0.02 Cr | -0.09% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | ₹2.34 Cr | 12.79% |
Cipla Ltd | Equity | ₹1.25 Cr | 6.83% |
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹1.19 Cr | 6.48% |
Divi's Laboratories Ltd | Equity | ₹1.08 Cr | 5.92% |
Dr Reddy's Laboratories Ltd | Equity | ₹1.07 Cr | 5.85% |
Apollo Hospitals Enterprise Ltd | Equity | ₹1.06 Cr | 5.82% |
Fortis Healthcare Ltd | Equity | ₹0.66 Cr | 3.61% |
Lupin Ltd | Equity | ₹0.64 Cr | 3.48% |
Torrent Pharmaceuticals Ltd | Equity | ₹0.52 Cr | 2.84% |
Laurus Labs Ltd | Equity | ₹0.46 Cr | 2.53% |
Glenmark Pharmaceuticals Ltd | Equity | ₹0.4 Cr | 2.19% |
Aurobindo Pharma Ltd | Equity | ₹0.4 Cr | 2.18% |
Alkem Laboratories Ltd | Equity | ₹0.4 Cr | 2.17% |
Mankind Pharma Ltd | Equity | ₹0.38 Cr | 2.09% |
Zydus Lifesciences Ltd | Equity | ₹0.34 Cr | 1.88% |
Biocon Ltd | Equity | ₹0.28 Cr | 1.52% |
Ipca Laboratories Ltd | Equity | ₹0.27 Cr | 1.46% |
Krishna Institute of Medical Sciences Ltd | Equity | ₹0.25 Cr | 1.35% |
Cohance Lifesciences Ltd | Equity | ₹0.23 Cr | 1.28% |
Abbott India Ltd | Equity | ₹0.22 Cr | 1.22% |
Gland Pharma Ltd | Equity | ₹0.21 Cr | 1.12% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹0.19 Cr | 1.06% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹0.19 Cr | 1.03% |
Dr. Lal PathLabs Ltd | Equity | ₹0.17 Cr | 0.95% |
Syngene International Ltd | Equity | ₹0.16 Cr | 0.90% |
Wockhardt Ltd | Equity | ₹0.16 Cr | 0.90% |
Narayana Hrudayalaya Ltd | Equity | ₹0.16 Cr | 0.90% |
Neuland Laboratories Ltd | Equity | ₹0.16 Cr | 0.88% |
Global Health Ltd | Equity | ₹0.16 Cr | 0.87% |
GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹0.16 Cr | 0.86% |
Piramal Pharma Ltd | Equity | ₹0.16 Cr | 0.85% |
Ajanta Pharma Ltd | Equity | ₹0.15 Cr | 0.80% |
Concord Biotech Ltd | Equity | ₹0.14 Cr | 0.75% |
Poly Medicure Ltd | Equity | ₹0.11 Cr | 0.61% |
Jubilant Pharmova Ltd | Equity | ₹0.11 Cr | 0.59% |
Pfizer Ltd | Equity | ₹0.11 Cr | 0.59% |
Natco Pharma Ltd | Equity | ₹0.11 Cr | 0.59% |
Rainbow Childrens Medicare Ltd | Equity | ₹0.11 Cr | 0.58% |
Eris Lifesciences Ltd Registered Shs | Equity | ₹0.11 Cr | 0.58% |
Granules India Ltd | Equity | ₹0.1 Cr | 0.54% |
Acutaas Chemicals Ltd | Equity | ₹0.1 Cr | 0.52% |
Metropolis Healthcare Ltd | Equity | ₹0.08 Cr | 0.43% |
Strides Pharma Science Ltd | Equity | ₹0.08 Cr | 0.43% |
Sai Life Sciences Ltd | Equity | ₹0.07 Cr | 0.41% |
AstraZeneca Pharma India Ltd | Equity | ₹0.07 Cr | 0.40% |
Jupiter Life Line Hospitals Ltd | Equity | ₹0.07 Cr | 0.40% |
Alembic Pharmaceuticals Ltd | Equity | ₹0.07 Cr | 0.39% |
Procter & Gamble Health Ltd | Equity | ₹0.07 Cr | 0.39% |
Vijaya Diagnostic Centre Ltd | Equity | ₹0.07 Cr | 0.37% |
Sanofi Consumer Healthcare India Ltd | Equity | ₹0.06 Cr | 0.35% |
Sanofi India Ltd | Equity | ₹0.06 Cr | 0.35% |
Shilpa Medicare Ltd | Equity | ₹0.06 Cr | 0.35% |
Aarti Pharmalabs Ltd | Equity | ₹0.06 Cr | 0.32% |
Indegene Ltd | Equity | ₹0.06 Cr | 0.32% |
Caplin Point Laboratories Ltd | Equity | ₹0.06 Cr | 0.32% |
Marksans Pharma Ltd | Equity | ₹0.05 Cr | 0.26% |
Emcure Pharmaceuticals Ltd | Equity | ₹0.05 Cr | 0.26% |
Net Current Assets | Cash | ₹-0.05 Cr | 0.26% |
Kovai Medical Center & Hospital Ltd | Equity | ₹0.04 Cr | 0.22% |
Alivus Life Sciences Ltd | Equity | ₹0.04 Cr | 0.22% |
HealthCare Global Enterprises Ltd | Equity | ₹0.04 Cr | 0.21% |
Yatharth Hospital and Trauma Care Services Ltd | Equity | ₹0.04 Cr | 0.19% |
FDC Ltd | Equity | ₹0.03 Cr | 0.17% |
Triparty Repo Trp_010925 | Cash - Repurchase Agreement | ₹0.03 Cr | 0.16% |
Sequent Scientific Ltd | Equity | ₹0.03 Cr | 0.15% |
Thyrocare Technologies Ltd | Equity | ₹0.03 Cr | 0.15% |
Indraprastha Medical Corp Ltd | Equity | ₹0.03 Cr | 0.15% |
Solara Active Pharma Sciences Ltd Ordinary Shares | Equity | ₹0.03 Cr | 0.15% |
Dishman Carbogen Amics Ltd | Equity | ₹0.02 Cr | 0.13% |
Supriya Lifescience Ltd | Equity | ₹0.02 Cr | 0.13% |
Morepen Laboratories Ltd | Equity | ₹0.02 Cr | 0.12% |
Aarti Drugs Ltd | Equity | ₹0.02 Cr | 0.12% |
Advanced Enzyme Technologies Ltd | Equity | ₹0.02 Cr | 0.12% |
Blue Jet Healthcare Ltd | Equity | ₹0.02 Cr | 0.12% |
Krsnaa Diagnostics Ltd | Equity | ₹0.02 Cr | 0.11% |
Innova Captab Ltd | Equity | ₹0.02 Cr | 0.11% |
Suven Life Sciences Ltd | Equity | ₹0.02 Cr | 0.10% |
Sun Pharma Advanced Research Co Ltd | Equity | ₹0.02 Cr | 0.10% |
Akums Drugs and Pharmaceuticals Ltd | Equity | ₹0.02 Cr | 0.09% |
Gujarat Themis Biosyn Ltd | Equity | ₹0.02 Cr | 0.09% |
Orchid Pharma Ltd | Equity | ₹0.02 Cr | 0.09% |
IOL Chemicals And Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.08% |
Unichem Laboratories Ltd | Equity | ₹0.01 Cr | 0.08% |
Bliss GVS Pharma Ltd | Equity | ₹0.01 Cr | 0.08% |
Senores Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.08% |
RPG Life Sciences Ltd | Equity | ₹0.01 Cr | 0.08% |
Gufic Biosciences Ltd | Equity | ₹0.01 Cr | 0.08% |
Indoco Remedies Ltd | Equity | ₹0.01 Cr | 0.07% |
Vimta Labs Ltd | Equity | ₹0.01 Cr | 0.07% |
Hikal Ltd | Equity | ₹0.01 Cr | 0.07% |
Windlas Biotech Ltd | Equity | ₹0.01 Cr | 0.06% |
Hester Biosciences Ltd | Equity | ₹0.01 Cr | 0.06% |
Syncom Formulation (India) Ltd | Equity | ₹0.01 Cr | 0.06% |
Artemis Medicare Services Ltd Ordinary Shares | Equity | ₹0.01 Cr | 0.05% |
SMS Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.05% |
Novartis India Ltd | Equity | ₹0.01 Cr | 0.05% |
Suraksha Diagnostic Ltd | Equity | ₹0.01 Cr | 0.04% |
Sigachi Industries Ltd | Equity | ₹0.01 Cr | 0.04% |
Shalby Ltd | Equity | ₹0.01 Cr | 0.04% |
Lincoln Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.04% |
Tarsons Products Ltd | Equity | ₹0.01 Cr | 0.04% |
GPT Healthcare Ltd | Equity | ₹0.01 Cr | 0.03% |
Kopran Ltd | Equity | ₹0.01 Cr | 0.03% |
Themis Medicare Ltd | Equity | ₹0 Cr | 0.02% |
KMC Speciality Hospitals (India) Ltd | Equity | ₹0 Cr | 0.02% |
NGL Fine-Chem Ltd | Equity | ₹0 Cr | 0.02% |
Sastasundar Ventures Ltd | Equity | ₹0 Cr | 0.02% |
Cash Margin - Ccil | Cash - Repurchase Agreement | ₹0 Cr | 0.00% |
Large Cap Stocks
53.98%
Mid Cap Stocks
20.31%
Small Cap Stocks
25.80%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹18.19 Cr | 99.44% |
Basic Materials | ₹0.12 Cr | 0.65% |
Standard Deviation
This fund
--
Cat. avg.
--
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
--
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
--
Higher the better
Since March 2025
ISIN INF194KB1IR4 | Expense Ratio 1.01% | Exit Load No Charges | Fund Size ₹18 Cr | Age 10 months | Lumpsum Minimum ₹1,000 | Fund Status Open Ended Investment Company | Benchmark BSE Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹1,83,484 Cr
Address
6th Floor, 841, One World Center, Mumbai, 400013
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments